Clinical risk stratification: Prague validation of the DAAE score, a clinical tool for estimating risk of disesase progression in multiple sclerosis
The DAAE score performs similarly between centers and using objective criteria. These validation steps support its use in personalized MS management and treatment.
Authors
- Tomáš Uher (ORCID: https://orcid.org/0000-0003-3160-9022)
- Tom A. Fuchs (ORCID: https://orcid.org/0000-0002-0219-3518)
- Menno Michiel Schoonheim (ORCID: https://orcid.org/0000-0002-2504-6959)
- Julia R. Jelgerhuis (ORCID: https://orcid.org/0009-0003-1320-7449)
- Eva Havrdová (ORCID: https://orcid.org/0000-0002-9543-4359)
- Dana Horáková (ORCID: https://orcid.org/0000-0003-3054-065X)
Institutions
- Charles University (CZ)
- Amsterdam Neuroscience (NL)
- General University Hospital in Prague (CZ)
Publication Details
- Journal
- Multiple Sclerosis and Related Disorders
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1016/j.msard.2025.106423
- Citations
- 1
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Univerzita Karlova v Praze
- European Committee for Treatment and Research in Multiple Sclerosis
- European Commission